STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Company

Lucid Diagnostics Inc.

Filed

February 24, 2022

Period of Report

February 18, 2022

Accession Number

0001062993-22-005542